1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Campbell, A.P.
Mcinnes, C.
Hodges, R.S.
Sykes, B.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
34
16255
16268
10.1021/bi00050a005
8845350
Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7, and PAK: implications for receptor binding and synthetic vaccine design.
1995
US
Biopolymers
BIPMAA
0161
0006-3525
34
1221
Conformational Differences between Cis and Trans Proline Isomers of a Peptide Antigen Representing the Receptor Binding Domain of Pseudomonas Aeruginosa as Studied by 1H NMR
1994
US
Biochemistry
BICHAW
0033
0006-2960
32
13432
NMR Solution Structure and Flexibility of a Peptide Antigen Representing the Receptor Binding Domain of Pseudomonas Aeruginosa
1993
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1943.182
PAK PILIN, TRANS
1
man
polymer
FIMBRIAL PROTEIN
no
yes
(ACE)KCTSDQDEQFIPKGCSK
XKCTSDQDEQFIPKGCSK
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Pseudomonas
K
sample
287
Pseudomonas aeruginosa
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1996-01-29
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1995-10-05
REL
REL
1
refinement
PEPFLEX II
ACE
127
n
1
ACE
127
A
LYS
128
n
2
LYS
128
A
CYS
129
n
3
CYS
129
A
THR
130
n
4
THR
130
A
SER
131
n
5
SER
131
A
ASP
132
n
6
ASP
132
A
GLN
133
n
7
GLN
133
A
ASP
134
n
8
ASP
134
A
GLU
135
n
9
GLU
135
A
GLN
136
n
10
GLN
136
A
PHE
137
n
11
PHE
137
A
ILE
138
n
12
ILE
138
A
PRO
139
n
13
PRO
139
A
LYS
140
n
14
LYS
140
A
GLY
141
n
15
GLY
141
A
CYS
142
n
16
CYS
142
A
SER
143
n
17
SER
143
A
LYS
144
n
18
LYS
144
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
CB
THR
130
PLANAR
1
A
A
C
H
SER
ASP
131
132
1.48
1
A
A
C
H
ACE
LYS
127
128
1.50
1
A
A
C
H
LYS
CYS
128
129
1.59
1
A
A
O
N
SER
ASP
131
132
1.67
1
A
A
O
N
ACE
LYS
127
128
1.70
1
A
A
C
N
ACE
LYS
127
128
1.03
1
A
A
C
N
LYS
CYS
128
129
1.08
1
A
A
C
N
CYS
THR
129
130
1.17
1
A
A
C
N
SER
ASP
131
132
1.04
1
A
A
C
N
CYS
SER
142
143
1.17
1
A
A
C
N
SER
LYS
143
144
1.10
1
28.60
2.20
113.40
142.00
A
A
A
CA
CB
CG
LYS
LYS
LYS
128
128
128
N
1
35.02
2.60
111.60
146.62
A
A
A
CB
CG
CD
LYS
LYS
LYS
128
128
128
N
1
41.63
3.00
111.90
153.53
A
A
A
CG
CD
CE
LYS
LYS
LYS
128
128
128
N
1
52.28
2.30
111.70
163.98
A
A
A
CD
CE
NZ
LYS
LYS
LYS
128
128
128
N
1
7.63
1.20
111.50
119.13
A
A
A
CB
CA
C
CYS
CYS
CYS
129
129
129
N
1
-17.95
2.30
110.00
92.05
A
A
A
OG1
CB
CG2
THR
THR
THR
130
130
130
N
1
11.51
1.40
112.40
123.91
A
A
A
CA
CB
CG2
THR
THR
THR
130
130
130
N
1
45.89
2.70
111.20
157.09
A
A
A
CA
CB
OG
SER
SER
SER
131
131
131
N
1
-10.09
1.60
122.70
112.61
A
A
A
O
C
N
SER
SER
ASP
131
131
132
Y
1
30.20
2.20
113.40
143.60
A
A
A
CA
CB
CG
ASP
ASP
ASP
132
132
132
N
1
-84.07
1.90
123.30
39.23
A
A
A
OD1
CG
OD2
ASP
ASP
ASP
132
132
132
N
1
42.65
0.90
118.30
160.95
A
A
A
CB
CG
OD1
ASP
ASP
ASP
132
132
132
N
1
41.51
0.90
118.30
159.81
A
A
A
CB
CG
OD2
ASP
ASP
ASP
132
132
132
N
1
-102.44
2.30
121.90
19.46
A
A
A
OE1
CD
NE2
GLN
GLN
GLN
133
133
133
N
1
49.69
2.00
121.60
171.29
A
A
A
CG
CD
OE1
GLN
GLN
GLN
133
133
133
N
1
52.55
2.40
116.70
169.25
A
A
A
CG
CD
NE2
GLN
GLN
GLN
133
133
133
N
1
-81.68
1.90
123.30
41.62
A
A
A
OD1
CG
OD2
ASP
ASP
ASP
134
134
134
N
1
42.67
0.90
118.30
160.97
A
A
A
CB
CG
OD1
ASP
ASP
ASP
134
134
134
N
1
39.12
0.90
118.30
157.42
A
A
A
CB
CG
OD2
ASP
ASP
ASP
134
134
134
N
1
-34.28
1.20
123.30
89.02
A
A
A
OE1
CD
OE2
GLU
GLU
GLU
135
135
135
N
1
22.15
2.00
118.30
140.45
A
A
A
CG
CD
OE1
GLU
GLU
GLU
135
135
135
N
1
12.23
2.00
118.30
130.53
A
A
A
CG
CD
OE2
GLU
GLU
GLU
135
135
135
N
1
28.50
2.20
113.40
141.90
A
A
A
CA
CB
CG
GLN
GLN
GLN
136
136
136
N
1
33.31
2.60
111.60
144.91
A
A
A
CB
CG
CD
GLN
GLN
GLN
136
136
136
N
1
-53.83
2.30
121.90
68.07
A
A
A
OE1
CD
NE2
GLN
GLN
GLN
136
136
136
N
1
26.23
2.00
121.60
147.83
A
A
A
CG
CD
OE1
GLN
GLN
GLN
136
136
136
N
1
27.40
2.40
116.70
144.10
A
A
A
CG
CD
NE2
GLN
GLN
GLN
136
136
136
N
1
52.38
0.70
120.80
173.18
A
A
A
CB
CG
CD2
PHE
PHE
PHE
137
137
137
N
1
-109.54
1.30
118.30
8.76
A
A
A
CD1
CG
CD2
PHE
PHE
PHE
137
137
137
N
1
53.68
0.70
120.80
174.48
A
A
A
CB
CG
CD1
PHE
PHE
PHE
137
137
137
N
1
54.48
1.10
120.80
175.28
A
A
A
CG
CD1
CE1
PHE
PHE
PHE
137
137
137
N
1
55.15
1.10
120.80
175.95
A
A
A
CG
CD2
CE2
PHE
PHE
PHE
137
137
137
N
1
55.59
1.20
120.10
175.69
A
A
A
CD1
CE1
CZ
PHE
PHE
PHE
137
137
137
N
1
-111.08
1.80
120.00
8.92
A
A
A
CE1
CZ
CE2
PHE
PHE
PHE
137
137
137
N
1
55.29
1.20
120.10
175.39
A
A
A
CZ
CE2
CD2
PHE
PHE
PHE
137
137
137
N
1
15.68
2.60
111.60
127.28
A
A
A
CB
CG
CD
LYS
LYS
LYS
140
140
140
N
1
19.82
2.30
111.70
131.52
A
A
A
CD
CE
NZ
LYS
LYS
LYS
140
140
140
N
1
52.90
2.70
111.20
164.10
A
A
A
CA
CB
OG
SER
SER
SER
143
143
143
N
1
36.56
2.20
113.40
149.96
A
A
A
CA
CB
CG
LYS
LYS
LYS
144
144
144
N
1
34.42
2.60
111.60
146.02
A
A
A
CB
CG
CD
LYS
LYS
LYS
144
144
144
N
1
34.53
3.00
111.90
146.43
A
A
A
CG
CD
CE
LYS
LYS
LYS
144
144
144
N
1
26.46
2.30
111.70
138.16
A
A
A
CD
CE
NZ
LYS
LYS
LYS
144
144
144
N
1
30.12
2.10
120.10
150.22
A
A
A
CA
C
O
LYS
LYS
LYS
144
144
144
N
1
A
A
C
N
ACE
LYS
127
128
-0.304
0.023
1.336
1.032
Y
1
A
A
N
CA
LYS
LYS
128
128
-0.347
0.020
1.459
1.112
N
1
A
A
CA
CB
LYS
LYS
128
128
-0.256
0.022
1.535
1.279
N
1
A
A
CB
CG
LYS
LYS
128
128
-0.491
0.027
1.521
1.030
N
1
A
A
CG
CD
LYS
LYS
128
128
-0.360
0.034
1.520
1.160
N
1
A
A
CD
CE
LYS
LYS
128
128
-0.488
0.025
1.508
1.020
N
1
A
A
CE
NZ
LYS
LYS
128
128
-0.456
0.025
1.486
1.030
N
1
A
A
CA
C
LYS
LYS
128
128
-0.266
0.026
1.525
1.259
N
1
A
A
C
O
LYS
LYS
128
128
-0.247
0.019
1.229
0.982
N
1
A
A
C
N
LYS
CYS
128
129
-0.258
0.023
1.336
1.078
Y
1
A
A
N
CA
CYS
CYS
129
129
-0.239
0.020
1.459
1.220
N
1
A
A
CA
CB
CYS
CYS
129
129
-0.173
0.013
1.526
1.353
N
1
A
A
CB
SG
CYS
CYS
129
129
-0.193
0.016
1.812
1.619
N
1
A
A
C
O
CYS
CYS
129
129
-0.154
0.019
1.229
1.075
N
1
A
A
C
N
CYS
THR
129
130
-0.162
0.023
1.336
1.174
Y
1
A
A
CA
CB
THR
THR
130
130
-0.219
0.026
1.529
1.310
N
1
A
A
CB
OG1
THR
THR
130
130
-0.638
0.020
1.428
0.790
N
1
A
A
CB
CG2
THR
THR
130
130
-0.595
0.033
1.519
0.924
N
1
A
A
CA
C
THR
THR
130
130
-0.177
0.026
1.525
1.348
N
1
A
A
C
O
THR
THR
130
130
-0.184
0.019
1.229
1.045
N
1
A
A
N
CA
SER
SER
131
131
-0.159
0.020
1.459
1.300
N
1
A
A
CA
CB
SER
SER
131
131
-0.362
0.015
1.525
1.163
N
1
A
A
CB
OG
SER
SER
131
131
-1.170
0.013
1.418
0.248
N
1
A
A
C
O
SER
SER
131
131
-0.259
0.019
1.229
0.970
N
1
A
A
C
N
SER
ASP
131
132
-0.296
0.023
1.336
1.040
Y
1
A
A
N
CA
ASP
ASP
132
132
-0.133
0.020
1.459
1.326
N
1
A
A
CA
CB
ASP
ASP
132
132
-0.200
0.022
1.535
1.335
N
1
A
A
CB
CG
ASP
ASP
132
132
-0.662
0.021
1.513
0.851
N
1
A
A
CG
OD1
ASP
ASP
132
132
-0.920
0.023
1.249
0.329
N
1
A
A
CG
OD2
ASP
ASP
132
132
-0.860
0.023
1.249
0.389
N
1
A
A
CA
C
ASP
ASP
132
132
-0.213
0.026
1.525
1.312
N
1
A
A
C
O
ASP
ASP
132
132
-0.286
0.019
1.229
0.943
N
1
A
A
N
CA
GLN
GLN
133
133
-0.185
0.020
1.459
1.274
N
1
A
A
CA
CB
GLN
GLN
133
133
-0.469
0.022
1.535
1.066
N
1
A
A
CB
CG
GLN
GLN
133
133
-0.444
0.027
1.521
1.077
N
1
A
A
CG
CD
GLN
GLN
133
133
-0.524
0.023
1.506
0.982
N
1
A
A
CD
OE1
GLN
GLN
133
133
-0.814
0.022
1.235
0.421
N
1
A
A
CD
NE2
GLN
GLN
133
133
-0.927
0.025
1.324
0.397
N
1
A
A
CB
CG
ASP
ASP
134
134
-0.192
0.021
1.513
1.321
N
1
A
A
CG
OD1
ASP
ASP
134
134
-0.705
0.023
1.249
0.544
N
1
A
A
CG
OD2
ASP
ASP
134
134
-0.675
0.023
1.249
0.574
N
1
A
A
CG
CD
GLU
GLU
135
135
-0.138
0.015
1.515
1.377
N
1
A
A
CD
OE1
GLU
GLU
135
135
-0.502
0.011
1.252
0.750
N
1
A
A
CD
OE2
GLU
GLU
135
135
-0.475
0.011
1.252
0.777
N
1
A
A
CB
CG
GLN
GLN
136
136
-0.566
0.027
1.521
0.955
N
1
A
A
CG
CD
GLN
GLN
136
136
-0.258
0.023
1.506
1.248
N
1
A
A
CD
OE1
GLN
GLN
136
136
-0.617
0.022
1.235
0.618
N
1
A
A
CD
NE2
GLN
GLN
136
136
-0.701
0.025
1.324
0.623
N
1
A
A
CG
CD2
PHE
PHE
137
137
-0.662
0.015
1.383
0.721
N
1
A
A
CG
CD1
PHE
PHE
137
137
-0.703
0.015
1.383
0.680
N
1
A
A
CE1
CZ
PHE
PHE
137
137
-0.661
0.019
1.369
0.708
N
1
A
A
CZ
CE2
PHE
PHE
137
137
-0.702
0.019
1.369
0.667
N
1
A
A
CB
CG
LYS
LYS
140
140
-0.434
0.027
1.521
1.087
N
1
A
A
CD
CE
LYS
LYS
140
140
-0.310
0.025
1.508
1.198
N
1
A
A
CE
NZ
LYS
LYS
140
140
-0.717
0.025
1.486
0.769
N
1
A
A
CA
CB
CYS
CYS
142
142
-0.107
0.013
1.526
1.419
N
1
A
A
CB
SG
CYS
CYS
142
142
-0.146
0.016
1.812
1.666
N
1
A
A
C
N
CYS
SER
142
143
-0.170
0.023
1.336
1.166
Y
1
A
A
CA
CB
SER
SER
143
143
-0.203
0.015
1.525
1.322
N
1
A
A
CB
OG
SER
SER
143
143
-0.894
0.013
1.418
0.524
N
1
A
A
CA
C
SER
SER
143
143
-0.217
0.026
1.525
1.308
N
1
A
A
C
O
SER
SER
143
143
-0.229
0.019
1.229
1.000
N
1
A
A
C
N
SER
LYS
143
144
-0.239
0.023
1.336
1.097
Y
1
A
A
N
CA
LYS
LYS
144
144
-0.212
0.020
1.459
1.247
N
1
A
A
CA
CB
LYS
LYS
144
144
-0.406
0.022
1.535
1.129
N
1
A
A
CB
CG
LYS
LYS
144
144
-0.516
0.027
1.521
1.005
N
1
A
A
CG
CD
LYS
LYS
144
144
-0.699
0.034
1.520
0.821
N
1
A
A
CD
CE
LYS
LYS
144
144
-0.478
0.025
1.508
1.030
N
1
A
A
CE
NZ
LYS
LYS
144
144
-0.821
0.025
1.486
0.665
N
1
A
A
CA
C
LYS
LYS
144
144
-0.392
0.026
1.525
1.133
N
1
A
A
C
O
LYS
LYS
144
144
-0.690
0.019
1.229
0.539
N
1
A
A
C
OXT
LYS
LYS
144
144
-0.684
0.019
1.229
0.545
N
1
A
SER
131
-83.31
-76.22
1
A
ASP
132
-103.61
-72.12
1
A
GLN
133
-153.08
85.78
PAK PILIN, TRANS
A COMPARISON OF NMR SOLUTION STRUCTURES OF THE RECEPTOR BINDING DOMAINS OF PSEUDOMONAS AERUGINOSA PILI STRAINS PAO, KB7, AND PAK: IMPLICATIONS FOR RECEPTOR BINDING AND SYNTHETIC VACCINE DESIGN
1
Y
N
disulf
1.242
A
CYS
129
A
SG
CYS
3
1_555
A
CYS
142
A
SG
CYS
16
1_555
covale
1.032
A
ACE
127
A
C
ACE
1
1_555
A
LYS
128
A
N
LYS
2
1_555
FIMBRIAL PROTEIN
FIMBRIAL PROTEIN
FMPA_PSEAE
UNP
1
1
P02973
MKAQKGFTLIELMIVVAIIGILAAIAIPQYQNYVARSEGASALASVNPLKTTVEEALSRGWSVKSGTGTEDATKKEVPLG
VAADANKLGTIALKPDPADGTADITLTFTMGGAGPKNKGKIITLTRTAADGLWKCTSDQDEQFIPKGCSK
134
150
1NIL
128
144
P02973
A
1
2
18
1
P 1